Jun. 24 at 7:54 PM
⏳️⌛️ Potential swing ideas 💡
✅️
$MAIA recently announced agreement with ROCHE for cancer therapies, recently announced positive phase 2 clinical trial, Noble Financial price target
$14, company focuses on novel telomere-targeting drug called THIO (ateganosine), aimed at telemerase-positive cancers, especially non-small cell lunch cancer (NSCLC) and pediatric high-trade gliomas, operates multiple clinical-stage programs with a team based in Chicago, upcoming catalysts: 1) update clinical data on efficacy/safety for phase 2
✅️
$EDBL back to consolidation from recent thigh above 6, small float, recently announced its Kick, sports nutrition won 2025 Mindful Award Sports Nutrition "Product of the Year", which launched on
$AMZN , also announced expansion of retail footprint across Northeast, company focused on growing organic herbs, lettuces and plant-based protein products using innovative greenhouse, hydroponic and vertical farming methods
🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D